BioNTech SE

NASDAQ:BNTX

Biotechnology

Healthcare
$83.26 -1.52%

-$1.41 today

Market cap
$20.64B
Beta
1.32
P/E (TTM)
-16.2
EPS (TTM)
-$4.93
52W Low $79.52High $124.00

Volume 1.24M

Average 1.11M

BNTX Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

BioNTech SENASDAQ: BNTX

Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares grows in line with its trailing trend

Q2 FY2026 weighted avg shares of 253.33M shares rose 4.8% year over year, ahead of the +3.0% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.2% from the prior quarter. Over 3 fiscal years it compounded at -0.2% a year.

Context

  • Weighted avg shares increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +4.8% holds above the trailing-twelve-month pace of +3.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
253.33M+0.2% QoQ
Last fiscal yearDec 2025
241.7M+0.5% YoY
LTMJun 2026
247.64M+3.0% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4.8%——
1 year+0.5%——
3-year CAGR-0.2%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
241.7M EUR
Year-over-year change
+0.5%
4-year CAGR
-0.2%

Weighted Avg Shares vs competitors

How BNTX compares with its peers on the latest reported figures

  • BNTX's LTM Jun 2026 weighted avg shares of 247.64M shares is the 4th highest of the 11 companies compared; the peer median is 134.22M shares.
  • Its year-over-year change of +3.0% is the 6th highest of 10, against a peer median of +4.2%.
  • Over three fiscal years its annual growth of -0.2% compares with a peer median of +2.9%.
BNTX Competitors Peer median
Weighted Avg Shares for BNTX and competitors
Company Period LTM YoY 3-year CAGR
IBRXImmunityBio, Inc.LTM Sep 20261.03B +20.6%+32.0%
GMABGenmab A/SLTM Jun 2026614.84M —-1.7%
IOVAIovance Biotherapeutics, Inc.LTM Sep 2026432.9M +30.6%+30.9%
BNTXBioNTech SELTM Jun 2026247.64M +3.0%-0.2%
INCYIncyte CorporationLTM Jun 2026198.21M +2.5%-4.2%
TGTXTG Therapeutics, Inc.LTM Sep 2026142.49M -2.4%+2.1%
IMTXImmatics N.V.LTM Mar 2026125.95M +14.7%+22.1%
CGENCompugen Ltd.LTM Mar 202693.98M +4.2%+2.6%
XNCRXencor, Inc.LTM Jun 202674.94M +5.1%+7.6%
MGNXMacroGenics, Inc.LTM Mar 202663.24M +0.8%+0.9%
IMCRImmunocore Holdings plcLTM Mar 202650.45M +0.8%+3.3%
Peer median (excluding BNTX) 134.22M+4.2%+2.9%

Competitors are the stored peer set for BNTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue18.98B17.31B3.82B2.75B2.76B
Cost of Revenue2.91B3B599.8M541.3M616.47M
Gross Profit16.07B14.32B3.22B2.21B2.14B
Gross Margin84.7%82.7%84.3%80.3%77.6%
Research & Development949.2M1.54B1.78B2.25B2.02B
Selling, General & Admin327.2M541.2M557.7M599M698.2M
Operating Expenses781.4M1.67B2.53B3.52B2.76B
Depreciation & Amortization75.2M123.3M183.4M298M367.69M
EBITDA15B13.1B1.38B(367.1M)(628M)
EBITDA Margin79.1%75.7%36.1%-13.3%-22.8%
Operating Income15.28B12.64B690.4M(1.31B)(623.87M)
Operating Margin80.5%73.0%18.1%-47.8%-22.6%
Interest Income1.56M47.37M351.31M0252.24M
Interest Expense5.63M15.82M7.76M13.16M13.64M
Other Income / Expenses(237.4M)311.4M495.7M636.6M(385.46M)
Income Before Tax15.05B12.95B1.19B(677.7M)(1.01B)
Pre-Tax Margin79.3%74.8%31.1%-24.6%-36.6%
Income Tax Expense4.75B3.52B255.8M(12.4M)81.93M
Net Income10.29B9.43B930.3M(665.3M)(1.09B)
Net Margin54.2%54.5%24.4%-24.2%-39.6%
EPS (Basic)43.8738.083.87(2.77)(4.51)
EPS (Diluted)41.2137.093.83(2.77)(4.51)
Weighted Avg Shares244M243.3M240.6M240.4M241.7M
Weighted Avg Shares (Diluted)259.7M249.8M242.7M240.4M241.7M

BioNTech SE

NASDAQ:BNTX

Intrinsic Alpha fair value

Locked

Current Price

$83.26

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.